Breast-carcinoma development presumably results from multiple mutational events in tumor-associated genes. Certain results indicate that some tumor-suppressor genes may combine their pathogenetic potential to synergistically promote tumor growth. In an effort to identify such mechanisms in breast tu
Detection of frequent allelic loss of 6q23–q25.2 in microdissected human breast cancer tissues
✍ Scribed by Hiroaki Fujii; Weibo Zhou; Edward Gabrielson
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 469 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Detection of alfelic loss in human breast cancer is hindered by the fact that breast cancer tissues are frequently infiltrated by stromal and inflammatory cells. For this study, we carefully microdissected infiltrating breast cancer tumor cells from contaminating normal cells and analyzed the DNA from these samples for allelic loss on the long arm of chromosome 6 by using a panel of 15 dinucleotide repeat markers. We found 53 of the 66 cases rrudied (80%) t o have allelic loss of either the entire chromosomal arm (37 cases) or a portion of the chromosomal arm ( I 6 cases). One common region that was identified for all tumors with deletions of 6q was the area between markers D65310/314 and D65473/255, consistent with a tumor suppressor gene locus at 6q23-6q25.2. The use of tissue microdissection allowed the detection of allelic loss,in this chromosomal region .in human breast cancer at a much higher frequency than was previously recognized.
📜 SIMILAR VOLUMES
In human endometrial cancer, we have previously identified a 790-kb region of common allelic loss in chromosome bands 10q25-q26, flanked by D10S587 and D10S1723. We constructed a contig covering the entire deleted region using YACs, PACs, and BACs. Five overlapping cosmid clones derived from YAC clo
To understand the molecular pathogenesis of human lung cancer, we analyzed allelic deletions on the long arm of chromosome 16 by PCR amplification of microsatellite markers. A total of 203 lung cancer specimens (78 squamous cell carcinomas and 125 adenocarcinomas) were analyzed. In both cell types,
A detailed analysis of loss of heterozygosity (LOH) in breast cancers was performed with 11 microsatellite markers on the long arm of chromosome 21. Among the 142 tumors examined, 44 (31%) showed LOH at one or more loci. Peak LOH frequency was observed on band 21q21. Deletion mapping identified a ne
Allelic losses on chromosome arm 22q are frequently observed in human meningiomas and in carcinomas of the colon, ovary, and breast. Among 140 primary breast cancers we examined for loss of heterozygosity (LOH) at 16 polymorphic loci on the long arm of chromosome 22, 56 (40%) showed LOH for at least